|
1
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ostrom QT, Gittleman H, Fulop J, Liu M,
Blanda R, Kromer C, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2008-2012. Neuro Oncol.
17(Suppl 4(Suppl 4)): iv1–iv62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al: Effects of radiotherapy with concomitant and
adjuvant temozolomide versus radiotherapy alone on survival in
glioblastoma in a randomised phase III study: 5-year analysis of
the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Davis ME: Glioblastoma: Overview of
disease and treatment. Clin J Oncol Nurs. 20(Suppl 5): S2–S8. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367:eaau69772020. View Article : Google Scholar :
|
|
7
|
Valadi H, Ekstrom K, Bossios A, Sjostrand
M, Lee JJ and Lotvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mashouri L, Yousefi H, Aref AR, Ahadi AM,
Molaei F and Alahari SK: Exosomes: Composition, biogenesis, and
mechanisms in cancer metastasis and drug resistance. Mol Cancer.
18:752019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Skog J, Wurdinger T, van Rijn S, Meijer
DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky
AM and Breakefield XO: Glioblastoma microvesicles transport RNA and
proteins that promote tumour growth and provide diagnostic
biomarkers. Nat Cell Biol. 10:1470–1476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pace KR, Dutt R and Galileo DS: Exosomal
L1CAM stimulates glioblastoma cell motility, proliferation, and
invasiveness. Int J Mol Sci. 20:39822019. View Article : Google Scholar :
|
|
11
|
Zhang Z, Yin J, Lu C, Wei Y, Zeng A and
You Y: Exosomal transfer of long non-coding RNA SBF2-AS1 enhances
chemoresistance to temozolomide in glioblastoma. J Exp Clin Cancer
Res. 38:1662019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang
G, Song J, Li Z, Zhang Z and Yuan W: Effect of exosomal miRNA on
cancer biology and clinical applications. Mol Cancer. 17:1472018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang B, Mao JH, Wang BY, Wang LX, Wen HY,
Xu LJ, Fu JX and Yang H: Exosomal miR-1910-3p promotes
proliferation, metastasis, and autophagy of breast cancer cells by
targeting MTMR3 and activating the NF-kB signaling pathway. Cancer
Lett. 489:87–99. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ghaemmaghami AB, Mahjoubin-Tehran M,
Movahedpour A, Morshedi K, Sheida A, Taghavi SP, Mirzaei H and
Hamblin MR: Role of exosomes in malignant glioma: MicroRNAs and
proteins in pathogenesis and diagnosis. Cell Commun Signal.
18:1202020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yin J, Zeng A, Zhang Z, Shi Z, Yan W and
You Y: Exosomal transfer of miR-1238 contributes to
temozolomide-resistance in glioblastoma. EBioMedicine. 42:238–251.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang J, Bai R, Li M, Ye H, Wu C, Wang C,
Li S, Tan L, Mai D, Li G, et al: Excessive miR-25-3p maturation via
N6− methyladenosine stimulated by cigarette smoke
promotes pancreatic cancer progression. Nat Commun. 10:18582019.
View Article : Google Scholar
|
|
17
|
Chen H, Pan H, Qian Y, Zhou W and Liu X:
MiR-25-3p promotes the proliferation of triple negative breast
cancer by targeting BTG2. Mol Cancer. 17:42018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang L, Tong Z, Sun Z, Zhu G, Shen E and
Huang Y: MiR-25-3p targets PTEN to regulate the migration,
invasion, and apoptosis of esophageal cancer cells via the PI3K/AKT
pathway. Biosci Rep. 40:BSR202019012020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ning L, Zhang M, Zhu Q, Hao F, Shen W and
Chen D: MiR-25-3p inhibition impairs tumorigenesis and invasion in
gastric cancer cells in vitro and in vivo. Bioengineered. 11:81–90.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rao HC, Wu ZK, Wei SD, Jiang Y, Guo QX,
Wang JW, Chen CX and Yang HY: MiR-25-3p serves as an oncogenic
MicroRNA by downregulating the expression of merlin in
osteosarcoma. Cancer Manag Res. 12:8989–9001. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ebert MS and Sharp PA: MicroRNA sponges:
Progress and possibilities. RNA. 16:2043–2050. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Lu Y, Zhao X, Liu Q, Li C, Graves-Deal R,
Cao Z, Singh B, Franklin JL, Wang J, Hu H, et al: lncRNA
MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance
via Wnt/β-catenin signaling. Nat Med. 23:1331–1341. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee SY: Temozolomide resistance in
glioblastoma multiforme. Genes Dis. 3:198–210. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim DK, Nishida H, An SY, Shetty AK,
Bartosh TJ and Prockop DJ: Chromatographically isolated CD63+CD81+
extracellular vesicles from mesenchymal stromal cells rescue
cognitive impairments after TBI. Proc Natl Acad Sci USA.
113:170–175. 2016. View Article : Google Scholar :
|
|
26
|
Peng G, Yang C, Liu Y and Shen C:
MiR-25-3p promotes glioma cell proliferation and migration by
targeting FBXW7 and DKK3. Exp Ther Med. 18:769–778. 2019.PubMed/NCBI
|
|
27
|
Peng G, Yuan X, Yuan J, Liu Q, Dai M, Shen
C, Ma J, Liao Y and Jiang W: MiR-25 promotes glioblastoma cell
proliferation and invasion by directly targeting NEFL. Mol Cell
Biochem. 409:103–111. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Davis RJ, Welcker M and Clurman BE: Tumor
suppression by the Fbw7 ubiquitin ligase: Mechanisms and
opportunities. Cancer Cell. 26:455–464. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin J, Ji A, Qiu G, Feng H, Li J, Li S,
Zou Y, Cui Y, Song C, He H and Lu Y: FBW7 is associated with
prognosis, inhibits malignancies and enhances temozolomide
sensitivity in glioblastoma cells. Cancer Sci. 109:1001–1011. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sailo BL, Banik K, Girisa S, Bordoloi D,
Fan L, Halim CE, Wang H, Kumar AP, Zheng D, Mao X, et al: FBXW7 in
cancer: What has been unraveled thus far? Cancers (Basel).
11:2462019. View Article : Google Scholar
|
|
31
|
Ibusuki M, Yamamoto Y, Shinriki S, Ando Y
and Iwase H: Reduced expression of ubiquitin ligase FBXW7 mRNA is
associated with poor prognosis in breast cancer patients. Cancer
Sci. 102:439–445. 2011. View Article : Google Scholar
|
|
32
|
Iwatsuki M, Mimori K, Ishii H, Yokobori T,
Takatsuno Y, Sato T, Toh H, Onoyama I, Nakayama KI, Baba H and Mori
M: Loss of FBXW7, a cell cycle regulating gene, in colorectal
cancer: Clinical significance. Int J Cancer. 126:1828–1837. 2010.
View Article : Google Scholar
|
|
33
|
Zeng AL, Yan W, Liu YW, Wang Z, Hu Q, Nie
E, Zhou X, Li R, Wang XF, Jiang T and You YP: Tumour exosomes from
cells harbouring PTPRZ1-MET fusion contribute to a malignant
phenotype and temozolomide chemoresistance in glioblastoma.
Oncogene. 36:5369–5381. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ding C, Yi X, Wu X, Bu X, Wang D, Wu Z,
Zhang G, Gu J and Kang D: Exosome-mediated transfer of circRNA
CircNFIX enhances temozolomide resistance in glioma. Cancer Lett.
479:1–12. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yuan Z, Yang Z, Li W, Wu A, Su Z and Jiang
B: Exosome-mediated transfer of long noncoding RNA HOTAIR regulates
temozolomide resistance by miR-519a-3p/RRM1 axis in glioblastoma.
Cancer Biother Radiopharm. 24–Jul;2020.Epub ahead of print.
View Article : Google Scholar
|
|
36
|
Yang JK, Yang JP, Tong J, Jing SY, Fan B,
Wang F, Sun GZ and Jiao BH: Exosomal miR-221 targets DNM3 to induce
tumor progression and temozolomide resistance in glioma. J
Neurooncol. 131:255–265. 2017. View Article : Google Scholar
|
|
37
|
Fujiwara T, Uotani K, Yoshida A, Morita T,
Nezu Y, Kobayashi E, Yoshida A, Uehara T, Omori T, Sugiu K, et al:
Clinical significance of circulating miR-25-3p as a novel
diagnostic and prognostic biomarker in osteosarcoma. Oncotarget.
8:33375–33392. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
ZiaSarabi P, Sorayayi S, Hesari A and
Ghasemi F: Circulating microRNA-133, microRNA-17 and microRNA-25 in
serum and its potential diagnostic value in gastric cancer. J Cell
Biochem. 120:12376–12381. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ebrahimkhani S, Vafaee F, Hallal S, Wei H,
Lee MYT, Young PE, Satgunaseelan L, Beadnall H, Barnett MH,
Shivalingam B, et al: Deep sequencing of circulating exosomal
microRNA allows non-invasive glioblastoma diagnosis. NPJ Precis
Oncol. 2:282018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zeng Z, Li Y, Pan Y, Lan X, Song F, Sun J,
Zhou K, Liu X, Ren X, Wang F, et al: Cancer-derived exosomal
miR-25-3p promotes pre-metastatic niche formation by inducing
vascular permeability and angiogenesis. Nat Commun. 9:53952018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Casadei L, Calore F, Creighton CJ,
Guescini M, Batte K, Iwenofu OH, Zewdu A, Braggio DA, Bill KL,
Fadda P, et al: Exosome-derived miR-25-3p and miR-92a-3p stimulate
liposarcoma progression. Cancer Res. 77:3846–3856. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hagedorn M, Delugin M, Abraldes I, Allain
N, Belaud-Rotureau MA, Turmo M, Prigent C, Loiseau H, Bikfalvi A
and Javerzat S: FBXW7/hCDC4 controls glioma cell proliferation in
vitro and is a prognostic marker for survival in glioblastoma
patients. Cell Div. 2:92007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kim HS, Woolard K, Lai C, Bauer PO, Maric
D, Song H, Li A, Kotliarova S, Zhang W and Fine HA: Gliomagenesis
arising from Pten- and Ink4a/Arf-deficient neural progenitor cells
is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
Cancer Res. 72:6065–6075. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang B, Xu M, Li M, Wu F, Hu S, Chen X,
Zhao L, Huang Z, Lan F, Liu D and Wang Y: MiR-25 promotes
cardiomyocyte proliferation by targeting FBXW7. Mol Ther Nucleic
Acids. 19:1299–1308. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li Z, Sun Y, Chen X, Squires J,
Nowroozizadeh B, Liang C and Huang J: p53 mutation directs AURKA
overexpression via miR-25 and FBXW7 in prostatic small cell
neuroendocrine carcinoma. Mol Cancer Res. 13:584–591. 2015.
View Article : Google Scholar :
|
|
46
|
Hua Y, Zhao K, Tao G, Dai C and Su Y:
MiR-25 promotes metastasis via targeting FBXW7 in esophageal
squamous cell carcinoma. Oncol Rep. 38:3030–3038. 2017. View Article : Google Scholar : PubMed/NCBI
|
